Full Text Journal Articles by
Author Robert E Bristow

Advertisement

Find full text journal articles






Rectosigmoid resection by gynecologic oncologists versus colorectal surgeons: as long as it catches the mouse, does the color of the cat matter?

Suk Joon Chang, Christina Fotopoulou, Robert E Bristow, Dennis S Chi, William A Cliby,

J Gynecol Oncol (Journal of gynecologic oncology)
[2021, 32(3):e51]

Cited: 0 times

View full text PDF listing >>



Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.

Victoria E Rodriguez, Alana M W LeBrón, Jenny Chang, Robert E Bristow,

<h4>Background</h4>Adherence to National Comprehensive Cancer Network guidelines have been adopted as the standard of care for various cancers and have been cited to have survival benefits. Few studies have examined the association of adherent treatment and endometrial cancer survival among various racial/ethnic groups and socioeconomic statuses.<h4>Methods</h4>Between January 1, 2006 and ... Read more >>

Cancer (Cancer)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Surgical Management of Gynecologic Cancers.

Kiran H Clair, Juliet Wolford, Jason A Zell, Robert E Bristow,

This article addresses the role of surgery in the management of gynecologic cancers with liver metastases. The authors review the short-term and long-term outcomes of aggressive resection through retrospective and randomized studies. Although the data supporting aggressive resection of liver metastasis are largely retrospective and case based, the randomized control ... Read more >>

Surg Oncol Clin N Am (Surgical oncology clinics of North America)
[2021, 30(1):69-88]

Cited: 0 times

View full text PDF listing >>



Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.

Brooke E Sanders, Samah Saharti, Katharina Laus, Robert E Bristow, Ramez N Eskander,

The objective of this study was to examine the rate of and indications for readmission in patients with advanced staged ovarian cancer undergoing rectosigmoid resection and primary anastomosis, an important quality metric. A retrospective review was conducted of patients with primary ovarian cancer who underwent rectosigmoid resection as part of ... Read more >>

J Obstet Gynaecol (Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology)
[2020, :1-6]

Cited: 0 times

View full text PDF listing >>



Ovarian cancer in California: Guideline adherence, survival, and the impact of geographic location, 1996-2014.

Carolina Villanueva, Jenny Chang, Argyrios Ziogas, Robert E Bristow, Verónica M Vieira,

<h4>Background</h4>Evidence suggests that geographic location may independently contribute to ovarian cancer survival. We aimed to investigate how the association between residential location and ovarian cancer-specific survival in California varies by race/ethnicity and socioeconomic status.<h4>Methods</h4>Additive Cox proportional hazard models were used to predict hazard ratios (HRs) and 95% confidence intervals (CI) ... Read more >>

Cancer Epidemiol (Cancer epidemiology)
[2020, 69:101825]

Cited: 0 times

View full text PDF listing >>



Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: A case for immune checkpoint salvage therapy in trophoblastic tumors.

Kiran H Clair, Nicolas Gallegos, Robert E Bristow,

•Cure rates are high for choriocarcinoma, however chemoresistant disease often leads to death.•High expression of PD-L1 suggests a role for checkpoint inhibitors in choriocarcinoma.•Pembrolizumab should be considered for salvage therapy for chemoresistant choriocarcinoma. ... Read more >>

Gynecol Oncol Rep (Gynecologic oncology reports)
[2020, 34:100625]

Cited: 1 time

View full text PDF listing >>



A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.

Robert E Bristow, Jenny Chang, Carolina Villanueva, Argyrios Ziogas, Veronica M Vieira,

<h4>Objective</h4>To validate the observed/expected ratio for adherence to ovarian cancer treatment guidelines as a risk-adjusted measure of hospital quality care, and to identify patient characteristics associated with disparities in access to high-performing hospitals.<h4>Methods</h4>This was a retrospective population-based study of stage I-IV invasive epithelial ovarian cancer reported to the California Cancer ... Read more >>

Obstet Gynecol (Obstetrics and gynecology)
[2020, 135(2):328-339]

Cited: 1 time

View full text PDF listing >>



Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.

Warren C Swegal, Robert J Herbert, David W Eisele, Jenny Chang, Robert E Bristow, Christine G Gourin,

<h4>Objectives/hypothesis</h4>To examine associations between survival and adherence to National Comprehensive Cancer Network (NCCN) treatment guidelines using an observed-to-expected (O/E) ratio for greater adherence as a risk-adjusted hospital measure of quality care in elderly patients treated for larynx cancer.<h4>Study design</h4>Retrospective analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare data.<h4>Methods</h4>Patients diagnosed with ... Read more >>

Laryngoscope (The Laryngoscope)
[2020, 130(3):672-678]

Cited: 1 time

View full text PDF listing >>



Impact of hospital care volume on clinical outcomes of laparoscopic radical hysterectomy for cervical cancer: A systematic review and meta-analysis.

Banghyun Lee, Kidong Kim, Youngmi Park, Myong Cheol Lim, Robert E Bristow,

<h4>Background</h4>In cervical cancer, the impact of hospital volume of laparoscopic radical hysterectomy (LRH) has not been investigated systematically as in ovarian cancer.The aim of this study was to investigate the impact of hospital care volume of LRH on treatment outcomes of patients with cervical cancer.<h4>Methods</h4>The PubMed, Embase, and Cochrane Library ... Read more >>

Medicine (Baltimore) (Medicine)
[2018, 97(49):e13445]

Cited: 2 times

View full text PDF listing >>



It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer.

Oliver Zivanovic, Dennis S Chi, Olga Filippova, Leslie M Randall, Robert E Bristow, Roisin E O'Cearbhaill,

The peritoneal spread of ovarian cancer makes it a potential target for hyperthermic intraperitoneal chemotherapy (HIPEC). Intraperitoneal delivery exposes the tumor to concentrations of cytotoxic drugs much greater than with intravenous delivery, and in vitro studies have also shown that combining hyperthermia and platinum leads to an additive cytotoxic effect. ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2018, 151(3):555-561]

Cited: 6 times

View full text PDF listing >>



Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study.

Myong Cheol Lim, Young-Joo Won, Jiwon Lim, Tahereh Salehi, Chong Woo Yoo, Robert E Bristow,

<h4>Background</h4>In this retrospective study, data from patients listed in the Korea Central Cancer Registry during 1993-2014 were analysed, to investigate the incidence and survival of second primary cancers (SPCs) after a diagnosis of primary peritoneal, epithelial ovarian, and fallopian tubal (POFT) cancer.<h4>Methods</h4>The standardised incidence ratio (SIR) and survival outcomes of ... Read more >>

BMC Cancer (BMC cancer)
[2018, 18(1):800]

Cited: 0 times

View full text PDF listing >>



Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.

Ramez N Eskander, James Kauderer, Krishnansu S Tewari, Robert S Mannel, Robert E Bristow, David M O'Malley, Stephen C Rubin, Gretchen E Glaser, Chad A Hamilton, Keiichi Fujiwara, Warner K Huh, Frederick Ueland, Jean-Marie Stephan, Robert A Burger,

<h4>Purpose</h4>We sought to determine the level of concordance among surgeons' assessment of residual disease (RD) and pre-treatment computed tomography (CT) findings among women who underwent optimal surgical cytoreduction for advanced stage ovarian cancer.<h4>Methods</h4>This is a post-trial ad hoc analysis of a phase 3 randomized clinical trial evaluating the impact of ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2018, 149(3):525-530]

Cited: 4 times

View full text PDF listing >>



Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.

Krista S Pfaendler, Jenny Chang, Argyrios Ziogas, Robert E Bristow, Kristine R Penner,

<h4>Objective</h4>To evaluate the association of sociodemographic and hospital characteristics with adherence to National Comprehensive Cancer Network treatment guidelines for stage IB-IIA cervical cancer and to analyze the relationship between adherent care and survival.<h4>Methods</h4>This is a retrospective population-based cohort study of patients with stage IB-IIA invasive cervical cancer reported to the ... Read more >>

Obstet Gynecol (Obstetrics and gynecology)
[2018, 131(5):899-908]

Cited: 4 times

View full text PDF listing >>



Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae.

Myong Cheol Lim, Young-Joo Won, Jiwon Lim, Sang-Soo Seo, Sokbom Kang, Chong Woo Yoo, Joo-Young Kim, Jae Hwan Oh, Robert E Bristow, Sang-Yoon Park,

To evaluate the incidence of colon cancer as a second primary cancer (CCSPC) and the survival outcomes of women with and without CCSPC after the diagnosis of endometrial cancer (EC).The standardized incidence ratio (SIR) of CCSPC and survival outcomes of EC survivors with and without CCSPC were analyzed using data ... Read more >>

J Cancer Res Clin Oncol (Journal of cancer research and clinical oncology)
[2018, 144(5):845-854]

Cited: 1 time

View full text PDF listing >>



Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study.

Stephanie Ricci, Ana I Tergas, Kara Long Roche, Melissa Gerardi Fairbairn, Kimberly L Levinson, Sean C Dowdy, Robert E Bristow, Micael Lopez, Katrina Slaughter, Kathleen Moore, Amanda N Fader,

A recent ASCO workforce study projects a significant shortage of oncologists in the U.S. by 2020, especially in rural/underserved (R/US) areas. The current study aim was to determine the patterns of distribution of U.S. gynecologic oncologists (GO) and to identify provider-based attitudes and barriers that may prevent GOs from practicing ... Read more >>

Gynecol Oncol Rep (Gynecologic oncology reports)
[2017, 22:100-104]

Cited: 2 times

View full text PDF listing >>



Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study.

Gary S Leiserowitz, Jeff F Lin, Ana I Tergas, William A Cliby, Robert E Bristow,

<h4>Objectives</h4>We performed a patterns-of-care study to characterize the types of patients with epithelial ovarian cancer (EOC) who received neoadjuvant chemotherapy (NACT) versus primary debulking surgery (PDS) using the National Cancer Database (NCDB).<h4>Methods</h4>We identified patients with stages IIIC and IV EOC in the NCDB diagnosed from 2003 to 2011. Patients who ... Read more >>

Int J Gynecol Cancer (International journal of gynecological cancer : official journal of the International Gynecological Cancer Society)
[2017, 27(4):675-683]

Cited: 3 times

View full text PDF listing >>



An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations.

Ritu Salani, Namita Khanna, Marina Frimer, Robert E Bristow, Lee-May Chen,

Gynecologic cancers account for ~12% of all new cancer cases in women and ~15% of all female cancer survivors. Current and continued advances within the field have resulted in long-term outcomes and a high rate of survivors. Therefore determining the most cost-effective clinical surveillance for detection of recurrence is critical. ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2017, 146(1):3-10]

Cited: 29 times

View full text PDF listing >>



Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma.

Tasha Serna-Gallegos, Nicolas Gallegos, Robert E Bristow,

•Cardiophrenic lymph node metastasis in low-grade ovarian carcinoma is rare.•Two cases presented here identify clinical strategies needing further attention.•Low-grade disease is treated with surgery given high chemotherapeutic resistance.•Preoperative awareness of lymph node metastasis allows for optimal debulking.•Identifying radiologic evidence of distant metastasis improves patient outcomes. ... Read more >>

Gynecol Oncol Rep (Gynecologic oncology reports)
[2017, 19:31-33]

Cited: 0 times

View full text PDF listing >>



Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.

Hee Seung Kim, Robert E Bristow, Suk-Joon Chang,

<h4>Objective</h4>The majority of advanced ovarian cancer patients have peritoneal carcinomatosis involving from the pelvis to upper abdomen, which is a major obstacle to optimal cytoreduction. Since total parietal peritonectomy was introduced for treating peritoneal carcinomatosis from colorectal cancer [3], similar surgical techniques including pelvic peritonectomy have been applied in advanced ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2016, 143(3):688-689]

Cited: 3 times

View full text PDF listing >>



Extended left upper quadrant resection during primary cytoreductive surgery for Stage IV ovarian cancer.

Brandon T Sawyer, Christopher J LaFargue, Robert E Bristow,

<h4>Objective</h4>The completeness of primary cytoreductive surgery for Stage IV epithelial ovarian cancer is associated with greater progression free survival and overall survival Winter et al. (2008) [1]. Cytoreduction to no gross residual disease in patients with bulky upper abdominal disease presents significant surgical challenges, highlighting the importance of specialized and ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2016, 142(2):378]

Cited: 0 times

View full text PDF listing >>



Surgical management of recurrent ovarian cancer.

Dong Hoon Suh, Hee Seung Kim, Suk-Joon Chang, Robert E Bristow,

Most patients with advanced-stage epithelial ovarian cancer will experience a relapse of disease despite a complete response after surgical cytoreduction and platinum-based chemotherapy. Treatment of recurrent ovarian cancer mainly comprises various combinations of systemic chemotherapy with or without targeted agents. The role of cytoreductive surgery for recurrent ovarian cancer is ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2016, 142(2):357-367]

Cited: 7 times

View full text PDF listing >>



Refusal of Recommended Chemotherapy for Ovarian Cancer: Risk Factors and Outcomes; a National Cancer Data Base Study.

Sumer K Wallace, Jeff F Lin, William A Cliby, Gary S Leiserowitz, Ana I Tergas, Robert E Bristow,

<h4>Objective</h4>To identify risk factors associated with refusal of recommended chemotherapy and its impact on patients with epithelial ovarian cancer (EOC).<h4>Methods</h4>We identified patients in the National Cancer Data Base diagnosed with EOC from January 1998 to December 2011. Patients who refused chemotherapy were identified and compared with those who received recommended, ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2016, 14(5):539-550]

Cited: 2 times

View full text PDF listing >>



Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity.

Amanda N Fader, R Matsuno Weise, Abdulrahman K Sinno, Edward J Tanner, Bijan J Borah, James P Moriarty, Robert E Bristow, Martin A Makary, Peter J Pronovost, Susan Hutfless, Sean C Dowdy,

<h4>Objective</h4>To describe case mix-adjusted hospital level utilization of minimally invasive surgery for hysterectomy in the treatment of early-stage endometrial cancer.<h4>Methods</h4>In this retrospective cohort study, we analyzed the proportion of patients who had a minimally invasive compared with open hysterectomy for nonmetastatic endometrial cancer using the U.S. Nationwide Inpatient Sample database, ... Read more >>

Obstet Gynecol (Obstetrics and gynecology)
[2016, 127(1):91-100]

Cited: 24 times

View full text PDF listing >>



Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.

Valerie B Galvan-Turner, Jenny Chang, Argyrios Ziogas, Robert E Bristow,

<h4>Objective</h4>To develop an observed-to-expected ratio (O/E) for adherence to National Comprehensive Cancer Network (NCCN) ovarian cancer treatment guidelines as a risk-adjusted hospital measure of quality care correlated with disease-specific survival.<h4>Methods</h4>Consecutive patients with stages I-IV epithelial ovarian cancer were identified from the California Cancer Registry (1/1/96-12/31/06). Using a fit logistic regression ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2015, 139(3):495-499]

Cited: 13 times

View full text PDF listing >>



Lifestyle and Weight Management Counseling in Uterine Cancer Survivors: A Study of the Uterine Cancer Action Network.

Jill H Tseng, Kara Long Roche, Amelia M Jernigan, Ritu Salani, Robert E Bristow, Amanda Nickles Fader,

<h4>Objective</h4>The purpose of this study was to examine the experiences, attitudes, and preferences of uterine cancer survivors with regard to weight and lifestyle counseling.<h4>Materials and methods</h4>Members of the US Uterine Cancer Action Network of the Foundation for Women's Cancer were invited to complete a 45-item, Web-based survey. Standard descriptive statistical ... Read more >>

Int J Gynecol Cancer (International journal of gynecological cancer : official journal of the International Gynecological Cancer Society)
[2015, 25(7):1285-1291]

Cited: 5 times

View full text PDF listing >>



Advertisement

Disclaimer
1.1033 s